Will Syros Pharmaceuticals Inc (SYRS) Underperform the Rest of the Stocks in the Healthcare Sector?

A rating of 37 puts Syros Pharmaceuticals Inc (SYRS) near the top of the Healthcare sector according to InvestorsObserver. Syros Pharmaceuticals Inc's score of 37 means that it ranks higher than 37% of stocks in the sector. In addition, its overall score of 24 ranks it higher than 24% of all stocks.

SYRS has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on SYRS!

See Full SYRS Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Syros Pharmaceuticals Inc Stock Today?

Syros Pharmaceuticals Inc (SYRS) stock is trading at $2.24 as of 10:22 AM on Tuesday, Oct 24, a gain of $0.03, or 1.36% from the previous closing price of $2.21. The stock has traded between $2.23 and $2.33 so far today. Volume today is light. So far 11,841 shares have traded compared to average volume of 58,948 shares. Click Here to get the full Stock Report for Syros Pharmaceuticals Inc stock.